COVID-19 Impact Analysis on Intravenous Iron Drugs Market report published by Value Market Research provides a detailed market analysis comprising market size, share, value, growth and trends for the period 2022-2028. The report encompasses data regarding market share and recent developments by key players. Moreover, this market report also covers regional and country markets in detail.
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the intravenous iron drugs market include Vifor Pharma Management Ltd., AMAG Pharmaceuticals, Daiichi Sankyo Company, Ltd. (American Regent. Inc.), Sanofi S.A., Pharmacosmos A/S, Shield Therapeutics Plc, AbbVie Inc. (Allergan Plc). This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
Get more information on "Global Intravenous Iron Drugs Market Research Report" by requesting FREE Sample Copy at https://www.valuemarketresearch.com/contact/intravenous-iron-drugs-market/download-sample
Market Dynamics
The growing incidences of chronic kidney diseases & anaemia may contribute to the growth of this market. The demand for the market is also rising due to the shifting trend from oral ferrous drugs to intravenous ferrous drugs. Moreover, increasing cases of inflammatory bowel disease (IBD) and cancer worldwide have increased demand for intravenous iron drugs, which is expected to drive market growth. The growing demand for intravenous iron drugs due to the rising research & development activities is fueling the global intravenous iron drugs market growth. Also, the increasing awareness of the diagnosis and treatment of anaemia is expected to scale up the market growth during the forecast period. However, the high cost of treatment may limit the growth of this market.
The research report covers Porter’s Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry’s structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of intravenous iron drugs. The growth and trends of intravenous iron drugs industry provide a holistic approach to this study.
Browse Global Intravenous Iron Drugs Market Research Report with detailed TOC at https://www.valuemarketresearch.com/report/intravenous-iron-drugs-market
Market Segmentation
This section of the intravenous iron drugs market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.
By Product
- Iron Dextran
- Iron Sucrose
- Ferric Carboxymaltose
- Others
By Application
- Chronic Kidney Disease
- Inflammatory Bowel Disease
- Cancer
- Others
Regional Analysis
This section covers the regional outlook, which accentuates current and future demand for the Intravenous Iron Drugs market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.
Purchase Complete Global Intravenous Iron Drugs Market Research Report at https://www.valuemarketresearch.com/contact/intravenous-iron-drugs-market/buy-now
About Us:
Value Market Research was established with the vision to ease decision making and empower the strategists by providing them with holistic market information.
We facilitate clients with syndicate research reports and customized research reports on 25+ industries with global as well as regional coverage.
Contact:
Value Market Research
401/402, TFM, Nagras Road, Aundh, Pune-7.
Maharashtra, INDIA.
Tel: +1-888-294-1147
Email: [email protected]
Website: https://www.valuemarketresearch.com
The global intravenous (IV) iron drugs market size is expected to reach USD 2.90 billion by 2026, expanding at a CAGR of 7.2% during the forecast period, according to a new report by Grand View Research.
Growing prevalence of chronic diseases, noncompliance of oral drug treatment and recent approvals of novel products are the key factors driving the IV iron drugs market.
However, some of the factors that are restraining the market include the adverse side effects, stringent regulations, availability of nutraceutical alternatives, and complex approval process.Iron is one of the crucial components in the hemoglobin and plays an important role in the transportation of oxygen throughout the body.
It also takes part in several biological processes such as energy metabolism, formation of collagen, the synthesis of heme, formation of myoglobin, immune system functions, and neurotransmitter production.
Around 30% of anemia in women and children in developing nations is caused by deficiency of iron according to a survey conducted by the Vitamin and Mineral Nutrition Information System in 2017.
Growing cases of chronic kidney diseases, iron deficiency anemia in gastroenterology, gynecology and oncology and growing cohort with high rate of unresponsive oral therapy is expected to drive the demand for these drugs.
